1. Home
  2. Additional Resources
  3. Peer-reviewed Articles and Reports
  4. Buprenorphine Induction in a Rural Maryland Detention Center During COVID-19: Implementation and Preliminary Outcomes of a Novel Telemedicine Treatment Program for Incarcerated Individuals With Opioid Use Disorder

Buprenorphine Induction in a Rural Maryland Detention Center During COVID-19: Implementation and Preliminary Outcomes of a Novel Telemedicine Treatment Program for Incarcerated Individuals With Opioid Use Disorder

This academic paper describes the implementation of a novel telemedicine treatment program that provided buprenorphine to incarcerated individuals in detention centers located in rural Maryland. Results of this flexible and innovative program are promising. The challenges and successes that this program faced are discussed in detail. 

Resource Type
Peer-reviewed Articles and Reports
Continuum of Care
Treatment
Response Approach
COVID / Coronavirus related
Medications for Opioid Use Disorder
Website
Buprenorphine Induction in a Rural Maryland Detention Center During COVID-19
Citation

Belcher, A. M., Coble, K., Cole, T. O., Welsh, C. J., Whitney, A., & Weintraub, E. (2021). Buprenorphine Induction in a Rural Maryland Detention Center During COVID-19: Implementation and Preliminary Outcomes of a Novel Telemedicine Treatment Program for Incarcerated Individuals With Opioid Use Disorder. Frontiers in psychiatry, 12, 703685.

State / region
Southeast
Maryland